Ami Fadia
Stock Analyst at Needham
(2.27)
# 2,421
Out of 4,829 analysts
409
Total ratings
37.02%
Success rate
-2.33%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Reiterates: Buy | $57 | $40.42 | +41.02% | 23 | May 8, 2025 | |
| AVDL Avadel Pharmaceuticals | Reiterates: Buy | $19 | $9.39 | +102.34% | 36 | May 8, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $30 → $27 | $6.45 | +318.60% | 20 | May 7, 2025 | |
| JAZZ Jazz Pharmaceuticals | Reiterates: Buy | $200 | $97.78 | +104.54% | 30 | May 7, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $49 | $34.06 | +43.88% | 37 | May 7, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $138 → $139 | $115.71 | +20.13% | 14 | May 6, 2025 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $80 | $38.35 | +108.60% | 11 | May 5, 2025 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $29 | $8.34 | +247.72% | 20 | May 2, 2025 | |
| BIIB Biogen | Reiterates: Hold | n/a | $118.17 | - | 40 | May 2, 2025 | |
| SAGE Sage Therapeutics | Reiterates: Hold | n/a | $6.57 | - | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $133 → $130 | $97.17 | +33.79% | 30 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.14 | +952.63% | 15 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.66 | +654.26% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $83 | $40.90 | +102.93% | 27 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $17.44 | +60.55% | 8 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $153 | $107.76 | +41.98% | 14 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $4.81 | - | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $10.38 | +2,982.85% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $25.12 | +198.57% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $1.02 | +2,105.88% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $27.01 | +133.25% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $2.44 | +104.92% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $16.93 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $2.11 | +942.65% | 4 | Jan 3, 2018 |
Revolution Medicines
May 8, 2025
Reiterates: Buy
Price Target: $57
Current: $40.42
Upside: +41.02%
Avadel Pharmaceuticals
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $9.39
Upside: +102.34%
Day One Biopharmaceuticals
May 7, 2025
Maintains: Buy
Price Target: $30 → $27
Current: $6.45
Upside: +318.60%
Jazz Pharmaceuticals
May 7, 2025
Reiterates: Buy
Price Target: $200
Current: $97.78
Upside: +104.54%
Harmony Biosciences Holdings
May 7, 2025
Reiterates: Buy
Price Target: $49
Current: $34.06
Upside: +43.88%
Neurocrine Biosciences
May 6, 2025
Maintains: Buy
Price Target: $138 → $139
Current: $115.71
Upside: +20.13%
Praxis Precision Medicines
May 5, 2025
Reiterates: Buy
Price Target: $80
Current: $38.35
Upside: +108.60%
Bicycle Therapeutics
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $8.34
Upside: +247.72%
Biogen
May 2, 2025
Reiterates: Hold
Price Target: n/a
Current: $118.17
Upside: -
Sage Therapeutics
Apr 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.57
Upside: -
Apr 28, 2025
Maintains: Buy
Price Target: $133 → $130
Current: $97.17
Upside: +33.79%
Apr 10, 2025
Reiterates: Buy
Price Target: $12
Current: $1.14
Upside: +952.63%
Apr 10, 2025
Reiterates: Buy
Price Target: $5
Current: $0.66
Upside: +654.26%
Apr 9, 2025
Reiterates: Buy
Price Target: $83
Current: $40.90
Upside: +102.93%
Apr 8, 2025
Reiterates: Buy
Price Target: $28
Current: $17.44
Upside: +60.55%
Apr 1, 2025
Reiterates: Buy
Price Target: $153
Current: $107.76
Upside: +41.98%
Feb 26, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.81
Upside: -
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $10.38
Upside: +2,982.85%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $25.12
Upside: +198.57%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $1.02
Upside: +2,105.88%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $27.01
Upside: +133.25%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $2.44
Upside: +104.92%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $16.93
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $2.11
Upside: +942.65%